Evommune, Inc. ·

EVMN 8-K 2026-06-29

Evommune, Inc. (EVMN) 8-K dated 2026-06-29 — accession 0001193125-26-286918. This URL is the filing, not the EVMN hub.

Evommune, Inc. (EVMN) common stock.

Evommune, Inc. filed a 8-K on 2026-06-29. Accession 0001193125-26-286918.

Cached items: 7.01, 8.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported EVMN revenue for 2025-12-31 was $13.0M. Net income was -$68.9M. Revenue was up 85.7% from 2024-12-31 to 2025-12-31. EVMN currently screens at market cap $0.

Not investment advice. The EVMN SEC hub lists recent forms. The stock page is the research view.

Source on EDGAR